European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19-Reference-Cited by-同舟云学术

European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19

Published:2023-05-01 Issue:4 Volume:13 Page:178-210
ISSN:2158-0014
Container-title:Brain Connectivity
language:en
Short-container-title:Brain Connectivity

Author:

Crook Harry¹,Ramirez Alfredo²³⁴⁵⁶,Hosseini Akram⁷^ORCID,Vavougyios Georgios⁸,Lehmann Clara⁹¹⁰¹¹,Bruchfeld Judith¹²,Schneider Anja³⁵,D'Avossa Giovanni¹³,Lo Re Vincenzina¹⁴,Salmoiraghi Alberto¹⁵¹⁶,Mukaetova-Ladinska Elizabeta¹⁷,Katshu Mohammad¹⁸,Boneschi Filippo M.¹⁹,Håkansson Krister²⁰,Geerlings Mirjam²¹,Pracht Elisabeth²,Ruiz Agustín²²,Jansen Jacobus F.A.²³,Snyder Heather²⁴,Kivipelto Miia²⁰,Edison Paul¹²⁵

Affiliation:

1. Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.

2. Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

3. Department of Neurodegenerative Diseases and Geriatric Psychiatry, Medical Faculty, University Hospital Bonn, Bonn, Germany.

4. Department of Psychiatry & Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, San Antonio, Texas, USA.

5. German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

6. Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

7. Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.

8. Department of Neurology, University of Cyprus, Lefkosia, Cyprus.

9. Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

10. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.

11. German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.

12. Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

13. School of Psychology, Bangor University, Bangor, United Kingdom.

14. Neurology Service, IRCCS-ISMETT, Palermo, Italy.

15. Mental Health Learning Disability Division, Betsi Cadwaladr University Health Board, Bangor, United Kingdom.

16. Glyndwr University, Wrexham, United Kingdom.

17. Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, United Kingdom.

18. School of Medicine, University of Nottingham, Nottingham, United Kingdom.

19. Division of Neuroscience and INSPE, San Raffaele Scientific Institute, Milan, Italy.

20. Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden.

21. University Medical Center Utrecht and Utrecht University, the Netherlands.

22. Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.

23. Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.

24. Alzheimer's Association, Chicago, Illinois, USA.

25. Cardiff University, Cardiff, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

General Neuroscience

Link

https://www.liebertpub.com/doi/pdf/10.1089/brain.2022.0058

Reference348 articles.

1. Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19

2. Long COVID after breakthrough SARS-CoV-2 infection

3. The impact of the COVID-19 pandemic on women’s mental health

4. Cognitive assessment in asymptomatic COVID-19 subjects

5. Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI evidence of gray matter loss in COVID‐19 patients with cognitive and olfactory disorders;Annals of Clinical and Translational Neurology;2024-07-30

2. SARS-CoV-2-Induced Type I Interferon Signaling Dysregulation in Olfactory Networks Implications for Alzheimer’s Disease;Current Issues in Molecular Biology;2024-05-10

3. The Therapeutic Potential of Melatonin in Alzheimer's Disease: A Comprehensive Review;Current Medicinal Chemistry;2024-03-28

4. Type I interferon signaling, cognition and neurodegeneration following COVID-19: update on a mechanistic pathogenetic model with implications for Alzheimer’s disease;Frontiers in Human Neuroscience;2024-03-18

5. The Impact of SARS-CoV-2 Infection on the Length of Stay in the Neuro-ICU:A Prospective Multicenter Cohort Study in Eight Neuro-ICU, China Between February and April 2023;Neuropsychiatric Disease and Treatment;2024-03